Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892496 · ClinicalTrials.gov registry record · NA
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
A NA study of Gingival Recession and Mucosal Erosion, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT06892496: Recruiting NA study of Gingival Recession and Mucosal Erosion, sponsored by Virginia Commonwealth University.
NCT06892496 is a NA study of Gingival Recession and Mucosal Erosion that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 42 participants, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (45% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06892496, a NA study of Gingival Recession and Mucosal Erosion, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This study has been initiated to evaluate the question, "What is the best way to protect the palate after a gum graft is removed?" The overall objective is to determine if there is a difference in PROMs of donor site healing using different palatal post-operative protection techniques.
Primary Outcome
Evaluate postoperative pain level by documenting the number of pain pills taken during the initial two weeks of the healing process.
Conditions Studied
Interventions
- OTHER Visual Analog scale (VAS) questionnaire
- OTHER Vacuum-formed retainer (VFR) technique
- OTHER 3-D printed acrylic resin stent (3DS) technique
- OTHER Flowable resin composite stent (FRC) technique
- OTHER Photographs of the patient's palate
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2025-03-07 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT06892496 shows while recruiting
NCT06892496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (45% higher).
The record links to 2 conditions, with Gingival Recession appearing as the primary indexed condition, and to 5 interventions - of which Visual Analog scale (VAS) questionnaire is the first listed.
NCT06892496 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06892496 about?
NCT06892496 is a clinical study titled "Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques". This study has been initiated to evaluate the question, "What is the best way to protect the palate after a gum graft is removed?" The overall objective is to determine if there is a difference in PROMs of donor site healing using different palatal post-operative protection techniques.
What is the current status of trial NCT06892496?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2025-03-07. Estimated completion is 2026-07.
What conditions does trial NCT06892496 study?
This clinical trial studies the following conditions: Gingival Recession, Mucosal Erosion.
What interventions are being tested in trial NCT06892496?
The interventions under investigation include: Visual Analog scale (VAS) questionnaire (OTHER), Vacuum-formed retainer (VFR) technique (OTHER), 3-D printed acrylic resin stent (3DS) technique (OTHER), Flowable resin composite stent (FRC) technique (OTHER), Photographs of the patient's palate (OTHER).
Who is sponsoring clinical trial NCT06892496?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06892496 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06892496's enrollment target sits among peer trials
42 3rd of 10 higher than 8 of 10 other Gingival Recession trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingival Recession trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Changes of Soft Tissue Grafting: A Randomized Study
RECRUITING · NA
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Thick vs. Thin Acellular Dermal Matrix (ADM)
COMPLETED · NA
-
Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
COMPLETED · NA
-
Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI